These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

128 related items for PubMed ID: 1327287

  • 1. Role of tumor necrosis factor-alpha and its specific 55-Kd and 75-Kd receptors in patients with lymphoproliferative disease of granular lymphocytes.
    Zambello R, Trentin L, Bulian P, Cassatella M, Raimondi R, Chisesi T, Agostini C, Semenzato G.
    Blood; 1992 Oct 15; 80(8):2030-7. PubMed ID: 1327287
    [Abstract] [Full Text] [Related]

  • 2. Different mechanisms of activation of proliferating CD3+ cells in patients with lymphoproliferative disease of granular lymphocytes.
    Zambello R, Cassatella MA, Trentin L, Bulian P, Siviero F, Feruglio C, Agostini C, Vespignani M, Chisesi T, Pizzolo G.
    Leukemia; 1991 Nov 15; 5(11):942-50. PubMed ID: 1835747
    [Abstract] [Full Text] [Related]

  • 3. Interleukin-15 triggers the proliferation and cytotoxicity of granular lymphocytes in patients with lymphoproliferative disease of granular lymphocytes.
    Zambello R, Facco M, Trentin L, Sancetta R, Tassinari C, Perin A, Milani A, Pizzolo G, Rodeghiero F, Agostini C, Meazza R, Ferrini S, Semenzato G.
    Blood; 1997 Jan 01; 89(1):201-11. PubMed ID: 8978293
    [Abstract] [Full Text] [Related]

  • 4. Cell membrane expression and functional role of the p75 subunit of interleukin-2 receptor in lymphoproliferative disease of granular lymphocytes.
    Zambello R, Trentin L, Pizzolo G, Bulian P, Masciarelli M, Feruglio C, Agostini C, Raimondi R, Chisesi T, Semenzato G.
    Blood; 1990 Nov 15; 76(10):2080-5. PubMed ID: 2146981
    [Abstract] [Full Text] [Related]

  • 5. The natural killer-related receptor for HLA-C expressed on T cells from CD3+ lymphoproliferative disease of granular lymphocytes displays either inhibitory or stimulatory function.
    Cambiaggi A, Orengo AM, Meazza R, Sforzini S, Tazzari PL, Lauria F, Raspadori D, Zambello R, Semenzato G, Moretta L, Ferrini S.
    Blood; 1996 Mar 15; 87(6):2369-75. PubMed ID: 8630400
    [Abstract] [Full Text] [Related]

  • 6. IL-12 is involved in the activation of CD3+ granular lymphocytes in patients with lymphoproliferative disease of granular lymphocytes.
    Zambello R, Trentin L, Cassatella MA, Raimondi R, Cerutti A, Enthammer C, Facco M, Agostini C, Semenzato G.
    Br J Haematol; 1996 Feb 15; 92(2):308-14. PubMed ID: 8602990
    [Abstract] [Full Text] [Related]

  • 7. Activation via the CD3 and CD16 pathway mediates interleukin-2-dependent autocrine proliferation of granular lymphocytes in patients with granular lymphocyte proliferative disorders.
    Hoshino S, Oshimi K, Teramura M, Mizoguchi H.
    Blood; 1991 Dec 15; 78(12):3232-40. PubMed ID: 1835892
    [Abstract] [Full Text] [Related]

  • 8. Analysis of TNF-receptor and ligand superfamily molecules in patients with lymphoproliferative disease of granular lymphocytes.
    Zambello R, Trentin L, Facco M, Siviero M, Galvan S, Piazza F, Perin A, Agostini C, Semenzato G.
    Blood; 2000 Jul 15; 96(2):647-54. PubMed ID: 10887130
    [Abstract] [Full Text] [Related]

  • 9. The lymphoproliferative disease of granular lymphocytes: updated criteria for diagnosis.
    Semenzato G, Zambello R, Starkebaum G, Oshimi K, Loughran TP.
    Blood; 1997 Jan 01; 89(1):256-60. PubMed ID: 8978299
    [Abstract] [Full Text] [Related]

  • 10. Expression and functional role of tumor necrosis factor receptors on leukemic cells from patients with type B chronic lymphoproliferative disorders.
    Trentin L, Zambello R, Agostini C, Siviero F, Adami F, Marcolongo R, Raimondi R, Chisesi T, Pizzolo G, Semenzato G.
    Blood; 1993 Feb 01; 81(3):752-8. PubMed ID: 8381309
    [Abstract] [Full Text] [Related]

  • 11. Phenotypic diversity of natural killer (NK) populations in patients with NK-type lymphoproliferative disease of granular lymphocytes.
    Zambello R, Trentin L, Ciccone E, Bulian P, Agostini C, Moretta A, Moretta L, Semenzato G.
    Blood; 1993 May 01; 81(9):2381-5. PubMed ID: 8481518
    [Abstract] [Full Text] [Related]

  • 12. Evidence that tumor necrosis factor alpha (TNF)-induced activation of neutrophil respiratory burst on biologic surfaces is mediated by the p55 TNF receptor.
    Menegazzi R, Cramer R, Patriarca P, Scheurich P, Dri P.
    Blood; 1994 Jul 01; 84(1):287-93. PubMed ID: 8018924
    [Abstract] [Full Text] [Related]

  • 13. Enhanced expression of tumor necrosis factor receptor mRNA and protein in mononuclear cells isolated from rheumatoid arthritis synovial joints.
    Brennan FM, Gibbons DL, Mitchell T, Cope AP, Maini RN, Feldmann M.
    Eur J Immunol; 1992 Jul 01; 22(7):1907-12. PubMed ID: 1320571
    [Abstract] [Full Text] [Related]

  • 14. Involvement of tumor necrosis factor (TNF) receptors p55 and p75 in TNF responses of acute myeloid leukemia blasts in vitro.
    Delwel R, van Buitenen C, Löwenberg B, Touw I.
    Blood; 1992 Oct 01; 80(7):1798-803. PubMed ID: 1382704
    [Abstract] [Full Text] [Related]

  • 15. Upregulation of CXCR1 by proliferating cells in patients with lymphoproliferative disease of granular lymphocytes.
    Zambello R, Trentin L, Facco M, Carollo D, Cabrelle A, Tosoni A, Cannas G, Nicolardi L, Agostini C, Semenzato G.
    Br J Haematol; 2003 Mar 01; 120(5):765-73. PubMed ID: 12614207
    [Abstract] [Full Text] [Related]

  • 16. Involvement of the 55- and 75-kDa tumor necrosis factor receptors in the generation of lymphokine-activated killer cell activity and proliferation of natural killer cells.
    Naume B, Shalaby R, Lesslauer W, Espevik T.
    J Immunol; 1991 May 01; 146(9):3045-8. PubMed ID: 1707931
    [Abstract] [Full Text] [Related]

  • 17. Independent expression of p55 and p75 interleukin-2 receptors (IL-2R) during intravenous or subcutaneous administration of recombinant interleukin-2 (rIL-2) by T-lymphocytes and natural killer cells.
    Zambello R, Trentin L, Cerutti A, Enthammer C, Milani A, Franceschi T, Messina C, Cetto GL, Agostini C, Semenzato G.
    Cancer; 1994 Nov 01; 74(9):2562-9. PubMed ID: 7522954
    [Abstract] [Full Text] [Related]

  • 18. The raft marker GM1 identifies functional subsets of granular lymphocytes in patients with CD3+ lymphoproliferative disease of granular lymphocytes.
    Zambello R, Cabrelle A, Trentin L, Agostini C, Semenzato G, Viola A.
    Leukemia; 2004 Apr 01; 18(4):771-6. PubMed ID: 15044927
    [Abstract] [Full Text] [Related]

  • 19. Combination anti-CD2 and anti-CD3 monoclonal antibodies induce tolerance while altering interleukin-2, interleukin-4, tumor necrosis factor, and transforming growth factor-beta production.
    Chavin KD, Qin L, Lin J, Woodward JE, Baliga P, Bromberg JS.
    Ann Surg; 1993 Oct 01; 218(4):492-501; discussion 501-3. PubMed ID: 8215640
    [Abstract] [Full Text] [Related]

  • 20. Interleukin-2 induces tumor necrosis factor-alpha production by activated human T cells via a cyclosporin-sensitive pathway.
    Lorré K, Fransen L, Ceuppens JL.
    Eur Cytokine Netw; 1992 Oct 01; 3(3):321-30. PubMed ID: 1353987
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.